With so much at stake, the decision to go ahead with a clinical trial must be well-founded. What is the market potential of the treatment under study? How far along are competitors in their development pipelines? What are the chances of success? Careful consideration – and a robust knowledge platform – wins the race.
Save time, money, and other resources while getting all the information you need to make the right decision: here's how DISQOVER's holistic search capabilities boost the efficiency of early drug discovery.
Identifying potential new targets for disease treatment is a top priority in life sciences: not only does it provide valuable insights, but it’s also key to getting an early-mover advantage over competitors. By integrating information from internal, public, and third-party sources in a highly efficient manner, DISQOVER dramatically speeds up this process.
Performing omics experiments in high throughput has become a standard technique in biomedical research. Omics data are abundant, but often, it isn't easy to find the subset you need. DISQOVER improves the annotation of omics data to avoid missing out on relevant subsets.
How do you go about searching for biomarkers? You have a ton of options at your disposal in the life sciences industry, but finding all these resources on your own can take a lot of time and energy. There is an easier way to do this: using a knowledge platform such as DISQOVER.
It is difficult to find appropriate experts because classifying knowledge and queries are often done manually. By locating subject matter experts and key opinion leaders to involve in research studies and clinical trials, DISQOVER improves finding experts based on expertise built-up in study or work.
Sifting existing literature for evidence relating to a research topic is a core element of clinical and life sciences research. With DISQOVER's unique features, finding, assembling, and curating that evidence become a lot less time-consuming – enhancing productivity and giving you a leg up on your competition.
